PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
84.43
-0.08 (-0.09%)
At close: Jun 26, 2026, 4:00 PM EDT
84.43
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:35 PM EDT
PTC Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for PTC Therapeutics stock have an average target of 97.3, with a low estimate of 82 and a high estimate of 124. The average target predicts an increase of 15.24% from the current stock price of 84.43.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PTC Therapeutics stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 5 | 5 | 6 | 7 |
| Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Hold | 4 | 4 | 5 | 5 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 15 | 14 | 14 | 15 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Initiates $75 → $108 | Buy | Initiates | $75 → $108 | +27.92% | Jun 9, 2026 |
| Barclays | Barclays | Buy Reiterates $120 | Buy | Reiterates | $120 | +42.13% | May 28, 2026 |
| Jefferies | Jefferies | Buy Upgrades $76 → $85 | Buy | Upgrades | $76 → $85 | +0.68% | May 27, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $80 → $89 | Buy | Maintains | $80 → $89 | +5.41% | May 11, 2026 |
Financial Forecast
Revenue This Year
1.17B
from 1.73B
Decreased by -32.21%
Revenue Next Year
1.31B
from 1.17B
Increased by 11.86%
EPS This Year
1.31
from 7.62
Decreased by -82.77%
EPS Next Year
2.78
from 1.31
Increased by 111.93%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.3B | 1.6B | |
| Avg | 1.2B | 1.3B | |
| Low | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -25.1% | 36.1% | |
| Avg | -32.2% | 11.9% | |
| Low | -37.6% | -6.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.71 | 4.18 | |
| Avg | 1.31 | 2.78 | |
| Low | 0.85 | 1.29 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -77.6% | 218.3% | |
| Avg | -82.8% | 111.9% | |
| Low | -88.8% | -1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.